The ALG6 Antibody (PACO7698) is a polyclonal antibody designed for research involving the ALG6 gene, which encodes for a key enzyme involved in the biosynthesis of asparagine-linked glycoproteins. The antibody, produced in rabbits, is highly specific and reactive with human samples, making it suitable for a variety of research applications.ALG6 is essential for the proper functioning of the glycosylation pathway, which is crucial for the post-translational modification of proteins. Dysregulation of this pathway has been implicated in various diseases, including congenital disorders of glycosylation and cancer.
The ALG6 Antibody enables researchers to study the expression and localization of ALG6 in different cell types, providing valuable insight into its role in glycoprotein biosynthesis.By understanding the function of ALG6 and its involvement in glycosylation processes, researchers can uncover new therapeutic targets for diseases associated with glycosylation defects. The ALG6 Antibody is a valuable tool for advancing research in fields such as molecular biology, cell biology, and biochemistry.
asparagine-linked glycosylation 6, α-1,3-glucosyltransferase homolog (S. cerevisiae);
UniProt Protein Function:
ALG6: Adds the first glucose residue to the lipid-linked oligosaccharide precursor for N-linked glycosylation. Transfers glucose from dolichyl phosphate glucose (Dol-P-Glc) onto the lipid-linked oligosaccharide Man(9)GlcNAc(2)-PP-Dol. Defects in ALG6 are the cause of congenital disorder of glycosylation type 1C (CDG1C); also known as carbohydrate-deficient glycoprotein syndrome type V. CDGs are metabolic deficiencies in glycoprotein biosynthesis that usually cause severe mental and psychomotor retardation. They are characterized by under-glycosylated serum glycoproteins. CDG1C patients have muscular hypotonia, show a delayed statomotor development and are mentally retarded. CDG1C is biochemically characterized by an accumulation of dolichyl pyrophosphate-linked Man(9)GlcNAc(2) in the endoplasmic reticulum. Belongs to the ALG6/ALG8 glucosyltransferase family.Protein type: Membrane protein, integral; Glycan Metabolism - N-glycan biosynthesis; EC 2.4.1.267; Membrane protein, multi-pass; TransferaseChromosomal Location of Human Ortholog: 1p31.3Cellular Component: endoplasmic reticulum membrane; membraneMolecular Function: dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity; dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity; glucosyltransferase activityBiological Process: dolichol-linked oligosaccharide biosynthetic process; oligosaccharide-lipid intermediate assembly; protein amino acid N-linked glycosylationDisease: Congenital Disorder Of Glycosylation, Type Ic
UniProt Protein Details:
NCBI Summary:
This gene encodes a member of the ALG6/ALG8 glucosyltransferase family. The encoded protein catalyzes the addition of the first glucose residue to the growing lipid-linked oligosaccharide precursor of N-linked glycosylation. Mutations in this gene are associated with congenital disorders of glycosylation type Ic. [provided by RefSeq, Jul 2008]